Identifier |
Protein names |
Gene names |
Cross reference refseq |
Length |
Species |
D0EWT7
|
Toll-like receptor 4; Fragment;
|
TLR-4;
|
NULL
|
169
|
human
|
Q5SB58
|
ATP synthase subunit a;
|
ATP6;
|
NULL
|
226
|
human
|
A0A024RCL6
|
Coiled-coil alpha-helical rod protein 1, isoform CRA_a;
|
CCHCR1;
|
NULL
|
782
|
human
|
V5JN33
|
NADH-ubiquinone oxidoreductase chain 3; EC 1.6.5.3;
|
ND3;
|
NULL
|
115
|
human
|
G5E9I9
|
Geminin coiled-coil domain-containing protein 1; HCG1644800;
|
GMNC;
|
NULL
|
63
|
human
|
Q6RA82
|
Microcephalin; Fragment;
|
MCPH1;
|
NULL
|
54
|
human
|
Q14Z33
|
NADH dehydrogenase subunit 5; Fragment;
|
NULL
|
NULL
|
81
|
human
|
A0A024R566
|
Splicing factor 1, isoform CRA_a;
|
SF1;
|
NULL
|
571
|
human
|
D3DSR9
|
Tumor necrosis factor receptor superfamily, member 10b; Tumor necrosis factor receptor superfamily, member 10b, isoform CRA_b;
|
TNFRSF10B;
|
NULL
|
411
|
human
|
Q9B2W6
|
Cytochrome c oxidase subunit 1; EC 1.9.3.1;
|
COX1;
|
NULL
|
513
|
human
|
A0A024RE11
|
Mal, T-cell differentiation protein, isoform CRA_b;
|
MAL;
|
NULL
|
138
|
human
|
G9LHW7
|
NADH-ubiquinone oxidoreductase chain 4; EC 1.6.5.3; Fragment;
|
ND4L;
|
NULL
|
85
|
human
|
J3QKN3
|
Cytochrome b-561, isoform CRA_c; Cytochrome b561;
|
CYB561;
|
NULL
|
194
|
human
|
A8K4F6
|
HCG15477, isoform CRA_b; cDNA FLJ76390;
|
NULL
|
NULL
|
132
|
human
|
A0A024QZU5
|
Peroxisomal D3,D2-enoyl-CoA isomerase, isoform CRA_a;
|
PECI;
|
NULL
|
364
|
human
|
H9S0I6
|
ATP synthase subunit a;
|
ATP6;
|
NULL
|
226
|
human
|
A0A024R0Z0
|
HCG1775530, isoform CRA_a;
|
NULL
|
NULL
|
27
|
human
|
Q5SQ83
|
Chromosome 6 open reading frame 17; Psoriasis susceptibility 1 candidate 2; Putative uncharacterized protein SPR1; SPR1;
|
SPR1; C6orf17 PSORS1C2;
|
NULL
|
136
|
human
|
A0A024QZ67
|
Tumor protein p53 inducible protein 13, isoform CRA_b;
|
TP53I13;
|
NULL
|
368
|
human
|
E5KPM7
|
8-oxoguanine DNA glycosylase, isoform CRA_j; N-glycosylase/DNA lyase;
|
OGG1;
|
NP_058437.1;
|
356
|
human
|